UTI - BSE Sensex Next 50 Exchange Traded Fund

A Equity ETF scheme from UTI Mutual Fund. Figures below are for the Direct · Growth plan (ISIN INF789F1AUU3).

NAV ₹94.2003 on 16 November 2026.

Expense ratio

Total expense ratio 0.31% a year for the Direct · Growth plan, as AMFI published it on 29 October 2026: base expense ratio 0.20%, brokerage 0.01%, transaction costs 0.00%, statutory levies including GST 0.10%.

Returns and risk

PeriodReturn a yearVolatilityWorst fallSharpeSortino
1 year0.9%17.0%-14.9%-0.36-0.33
3 years15.6%17.2%-20.7%0.500.45
5 years12.7%17.1%-20.7%0.330.29

Too little NAV history for the 10-year figures.

Not ranked in its category: its category mixes funds too different to rank against one another.

Largest holdings

Top 10 (September 2026 disclosure). Company shares make up 100.0% of the portfolio.

  1. Divi's Laboratories Limited — 4.37%
  2. Adani Enterprises Limited — 3.63%
  3. Tata Motors Limited — 3.27%
  4. Adani Power Limited — 3.19%
  5. The Federal Bank Limited — 2.90%
  6. Samvardhana Motherson International Limited — 2.67%
  7. One 97 Communications Limited — 2.66%
  8. Cholamandalam Investment and Finance Company Limited — 2.60%
  9. Hero MotoCorp Limited — 2.48%
  10. Cummins India Limited — 2.39%

Plans

Other funds in Equity ETF

All 86 funds in Equity ETF · Compare this fund with another

Past returns are history, not a forecast. XIRRO describes funds and portfolios; it is information, not investment advice.